3 Year return
15.32%Investment Details
Calculate Returns
Based on past performance of this fund
Risk Involved
Your principal will be at
Very High Risk
Asset Under Management
₹7132.82 Cr.
Expense Ratio
0.92% (inclusive of GST)
Exit Load
1% if redeemed or switchd out on or efore completion of 1 Months from the date of allotment of units. NIl if redeemed or switched out after the completion of 1 Months from the date of allotment of units.
Tax Implications
Withdrawal within 1 year
Exit load + 15% tax on gains
Withdrawal after 1 year
10% tax on gains over ₹1 Lakh per financial year
Fund Holdings
Other Holdings | % of Asset |
---|---|
Dr Reddy's Labs | 4.78 % |
Gland Pharma | 4.08 % |
TREPS | 3.92 % |
J B Chem & Pharm | 3.7 % |
Zydus Lifesci. | 3.61 % |
Abbott India | 3.2 % |
Vijaya Diagnost. | 3.1 % |
Ajanta Pharma | 3.01 % |
Medplus Health | 3.01 % |
Mankind Pharma | 2.99 % |
Aurobindo Pharma | 2.91 % |
Sanofi India | 2.75 % |
Narayana Hrudaya | 2.71 % |
Alkem Lab | 2.56 % |
Glaxosmi. Pharma | 2.5 % |
Torrent Pharma. | 2.24 % |
Pfizer | 1.9 % |
Fortis Health. | 1.72 % |
Thyrocare Tech. | 1.6 % |
Orchid Pharma | 1.09 % |
Syngene Intl. | 1.09 % |
Indoco Remedies | 0.84 % |
Concord Biotech | 0.59 % |
Metropolis Healt | 0.53 % |
Astrazeneca Phar | 0.48 % |
Health.Global | 0.21 % |
Jubilant Pharmo | 0.07 % |
C C I | 0.02 % |
Net CA & Others | -0.11 % |
Nippon India Mutual Fund Managers
SB
Sailesh Raj Bhan
Fund Manager since May 2018
Fund House Details
Nippon India Mutual Fund Asset management company
Peer Comparison
Comparison with other similar funds
Funds
|
3 Y Returns
|
ARQ Rating
|
---|---|---|
Invesco India PSU Equity Fund Direct Plan IDCW (Payout / Payout) |
42.14% |
0 |
Quant Infrastructure Fund IDCW Direct Plan Payout |
38.55% |
0 |
Invesco India Infrastructure Fund Direct Plan IDCW (Payout / Payout) |
37.43% |
0 |
Schemes by Nippon India Mutual Fund
List of mutual fund schemes by AMC
Hybrid . Arbitrage Fund
Nippon India Arbitrage Fund Direct Plan Monthly IDCW Payout
Hybrid . Arbitrage Fund
Nippon India Arbitrage Fund Direct Plan Monthly IDCW Reinvestment
Hybrid . Arbitrage Fund
Nippon India Arbitrage Fund Direct Plan IDCW Payout
Hybrid . Arbitrage Fund
Nippon India Arbitrage Fund Direct Plan IDCW Reinvestment
Hybrid . Arbitrage Fund
Nippon India Arbitrage Fund Direct Plan Growth
About Nippon India Pharma Fund Direct Plan IDCW Payout
Nippon India Pharma Fund Direct Plan IDCW Payout is an open-ended fund offered by Nippon India Mutual Funds. This is a thematic fund. Nippon India Pharma Fund Direct Plan IDCW Payout is a mutual fund that invests in a diversified portfolio of pharmaceutical companies. The fund aims to generate long-term capital appreciation by investing in companies that are involved in the development, manufacturing, and distribution of pharmaceuticals. It’s an IDCW fund, meaning the fund will distribute a portion of its net income to its investors.
Investment Objectives of the Scheme
The investment objective of the Nippon India Pharma Fund Direct Plan IDCW Payout is to generate long-term capital from investing in a portfolio of pharmaceutical companies' stocks. The fund also aims to provide investors with regular income from their investments. The ideal holding period is 5 years or more.
Key Features of The Fund
5-year return | 25.54% |
Expense Ratio | 0.92% |
Fund Manager | Sailesh Raj Bhan |
Fund Size | ₹7132.82 Cr |
Risk Profile | Very High |
Is This Scheme Right for Me?
Nippon India Pharma Fund Direct Plan IDCW Payout is a good option for investors who are looking for a long-term investment that can generate capital appreciation and provide them with regular income. The fund is also a good option for investors who are willing to take on some risk in exchange for the potential for higher returns.
AMC Contact Details
Name | Nippon India Mutual Fund |
Launch Date | June 1995 |
Addresss | Nippon Life India Asset Management Limited, 4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W), Mumbai – 400 013 |
Contact | 1860 266 0111 |
customercare@nipponindiaim.in | |
Website | https://mf.nipponindiaim.com/ |
Disclaimer: Mutual funds are subject to market risk. Read all scheme-related documents carefully to make informed-decision.